lncRNA XIST promotes glioma proliferation and metastasis through miR‑133a/SOX4

Luo,Chixing; Quan,Zhongping; Zhong,Bao; Zhang,Ming; Zhou,Bo; Wang,Shaobo; Luo,Xinkai; Tang,Changjiu

doi:10.3892/etm.2020.8426

lncRNA XIST promotes glioma proliferation and metastasis through miR‑133a/SOX4

Authors:
- Chixing Luo
- Zhongping Quan
- Bao Zhong
- Ming Zhang
- Bo Zhou
- Shaobo Wang
- Xinkai Luo
- Changjiu Tang
View Affiliations

Affiliations: Department of Neurosurgery, Jingmen No. 2 People's Hospital, Jingmen, Hubei 448000, P.R. China
Published online on: January 7, 2020 https://doi.org/10.3892/etm.2020.8426
Pages: 1641-1648
Copyright: © Luo et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Glioma is the most common malignant brain tumour in adults, and the aetiology and mechanism of this tumour remain largely unknown. Previous studies have demonstrated that the long non‑coding RNA X‑inactive specific transcript (XIST) is upregulated in many cancers, and a high expression level of XIST is associated with poor clinical outcome. In the present study, the expression and function of XIST were investigated in the glioma cell line U251. XIST and microRNA (miR)‑133a levels in glioma cell lines were detected by reverse transcription‑quantitative polymerase chain reaction. Small hairpin RNA XIST (sh‑XIST) and mimics/inhibitor of miR‑133a were transfected in glioma cell lines and cell proliferation, invasion, migration and epithelial‑mesenchymal transition (EMT) were examined. Luciferase assays were used to verify the associations among XIST, miR‑133a and SRY‑box (SOX)4. When XIST was knocked down, the proliferation, metastasis and EMT of glioma cells decreased. Notably, downstream genes of SOX4 were also upregulated or downregulated upon sh‑XIST treatment. Overexpression of miR‑133a inhibited glioma proliferation, metastasis and EMT via reducing the expression of SOX4; in contrast, knockdown of miR‑133a exhibited the opposite effect, which revealed that miR‑133a negatively regulates glioma progression. Furthermore, using luciferase assays, it was demonstrated that XIST and SOX4 could bind miR‑133a in the predicted binding site; XIST competed with SOX4 for miR‑133a binding. In conclusion, a XIST/miR‑133a/SOX4 axis and a mechanism of XIST glioma in promoting cell proliferation and metastasis were revealed. These findings revealed that XIST has an oncogenic role in the tumourigenesis of glioma and may serve as a potential therapeutic target for glioma.

View Figures

View References

1	Goodenberger ML and Jenkins RB: Genetics of adult glioma. Cancer Genet. 205:613–621. 2012. View Article : Google Scholar : PubMed/NCBI
2	Prados MD and Levin V: Biology and treatment of malignant glioma. Semin Oncol. 27 (Suppl 6):S1–S10. 2000.
3	Maher EA, Furnari FB, Bachoo RM, Rowitch DH, Louis DN, Cavenee WK and DePinho RA: Malignant glioma: Genetics and biology of a grave matter. Genes Dev. 15:1311–1333. 2001. View Article : Google Scholar : PubMed/NCBI
4	Yarmishyn AA and Kurochkin IV: Long noncoding RNAs: A potential novel class of cancer biomarkers. Front Genet. 6:1452015. View Article : Google Scholar : PubMed/NCBI
5	Yang W, Yu H, Shen Y, Liu Y, Yang Z and Sun T: MiR-146b-5p overexpression attenuates stemness and radioresistance of glioma stem cells by targeting HuR/lincRNA-p21/β-catenin pathway. Oncotarget. 7:41505–41526. 2016.PubMed/NCBI
6	Feng S, Yao J, Chen Y, Geng P, Zhang H, Ma X, Zhao J and Yu X: Expression and functional role of reprogramming-related long noncoding RNA (lincRNA-ROR) in glioma. J Mol Neurosci. 56:623–630. 2015. View Article : Google Scholar : PubMed/NCBI
7	Wutz A: Gene silencing in X-chromosome inactivation: Advances in understanding facultative heterochromatin formation. Nat Rev Genet. 12:542–553. 2011. View Article : Google Scholar : PubMed/NCBI
8	Wang Z, Yuan J, Li L, Yang Y, Xu X and Wang Y: Long non-coding RNA XIST exerts oncogenic functions in human glioma by targeting miR-137. Am J Transl Res. 9:1845–1855. 2017.PubMed/NCBI
9	Wei W, Liu Y, Lu Y, Yang B and Tang L: LncRNA XIST promotes pancreatic cancer proliferation through miR-133a/EGFR. J Cell Biochem. 118:3349–3358. 2017. View Article : Google Scholar : PubMed/NCBI
10	Li S, Qin X, Li Y, Zhang X, Niu R, Zhang H, Cui A, An W and Wang X: MiR-133a suppresses the migration and invasion of esophageal cancer cells by targeting the EMT regulator SOX4. Am J Transl Res. 7:1390–1403. 2015.PubMed/NCBI
11	Jafarnejad SM, Ardekani GS, Ghaffari M and Li G: Pleiotropic function of SRY-related HMG box transcription factor 4 in regulation of tumorigenesis. Cell Mol Life Sci. 70:2677–2696. 2013. View Article : Google Scholar : PubMed/NCBI
12	Schilham MW, Oosterwegel MA, Moerer P, Ya J, de Boer PA, van de Wetering M, Verbeek S, Lamers WH, Kruisbeek AM, Cumano A and Clevers H: Defects in cardiac outflow tract formation and pro-B-lymphocyte expansion in mice lacking Sox-4. Nature. 380:711–714. 1996. View Article : Google Scholar : PubMed/NCBI
13	Ya J, Schilham MW, de Boer PA, Moorman AF, Clevers H and Lamers WH: Sox4-deficiency syndrome in mice is an animal model for common trunk. Circ Res. 83:986–994. 1998. View Article : Google Scholar : PubMed/NCBI
14	Cheung M, Abu-Elmagd M, Clevers H and Scotting PJ: Roles of Sox4 in central nervous system development. Brain Res Mol Brain Res. 79:180–191. 2000. View Article : Google Scholar : PubMed/NCBI
15	Chen J, Ju HL, Yuan XY, Wang TJ and Lai BQ: SOX4 is a potential prognostic factor in human cancers: A systematic review and meta-analysis. Clin Transl Oncol. 18:65–72. 2016. View Article : Google Scholar : PubMed/NCBI
16	Shi S, Cao X, Gu M, You B, Shan Y and You Y: Upregulated expression of SOX4 is associated with tumor growth and metastasis in nasopharyngeal carcinoma. Dis Markers. 2015:6581412015. View Article : Google Scholar : PubMed/NCBI
17	Foronda M, Martínez P, Schoeftner S, Gómez-López G, Schneider R, Flores JM, Pisano DG and Blasco MA: Sox4 links tumor suppression to accelerated aging in mice by modulating stem cell activation. Cell Rep. 8:487–500. 2014. View Article : Google Scholar : PubMed/NCBI
18	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
19	Khachane AN and Harrison PM: Mining mammalian transcript data for functional long non-coding RNAs. PLoS One. 5:e103162010. View Article : Google Scholar : PubMed/NCBI
20	Zhang L, Cao X, Zhang L, Zhang X, Sheng H and Tao K: UCA1 overexpression predicts clinical outcome of patients with ovarian cancer receiving adjuvant chemotherapy. Cancer Chemother Pharmacol. 77:629–634. 2016. View Article : Google Scholar : PubMed/NCBI
21	Song H, He P, Shao T, Li Y, Li J and Zhang Y: Long non-coding RNA XIST functions as an oncogene in human colorectal cancer by targeting miR-132-3p. J BUON. 22:696–703. 2017.PubMed/NCBI
22	Tang Y, He R, An J, Deng P, Huang L and Yang W: lncRNA XIST interacts with miR-140 to modulate lung cancer growth by targeting iASPP. Oncol Rep. 38:941–948. 2017. View Article : Google Scholar : PubMed/NCBI
23	Dai W, Xu X, Li S, Ma J, Shi Q, Guo S, Liu L, Guo W, Xu P, He Y, et al: SOX4 promotes proliferative signals by regulating glycolysis through AKT activation in melanoma cells. J Invest Dermatol. 137:2407–2416. 2017. View Article : Google Scholar : PubMed/NCBI
24	Vervoort SJ, van Boxtel R and Coffer PJ: The role of SRY-related HMG box transcription factor 4 (SOX4) in tumorigenesis and metastasis: Friend or foe? Oncogene. 32:3397–3409. 2013. View Article : Google Scholar : PubMed/NCBI
25	Vervoort SJ, Lourenco AR, van Boxtel R and Coffer PJ: SOX4 mediates TGF-β-induced expression of mesenchymal markers during mammary cell epithelial to mesenchymal transition. PLoS One. 8:e532382013. View Article : Google Scholar : PubMed/NCBI
26	Manalo DJ, Rowan A, Lavoie T, Natarajan L, Kelly BD, Ye SQ, Garcia JG and Semenza GL: Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood. 105:659–669. 2005. View Article : Google Scholar : PubMed/NCBI
27	Banno T, Gazel A and Blumenberg M: Effects of tumor necrosis factor-alpha (TNF alpha) in epidermal keratinocytes revealed using global transcriptional profiling. J Biol Chem. 279:32633–32642. 2004. View Article : Google Scholar : PubMed/NCBI
28	Mishra P and Chan DC: Metabolic regulation of mitochondrial dynamics. J Cell Boil. 212:379–387. 2016. View Article : Google Scholar
29	Mei Q, Li X, Guo M, Fu X and Han W: The miRNA network: Micro-regulator of cell signalling in cancer. Expert Rev Anticancer Ther. 14:1515–1527. 2014. View Article : Google Scholar : PubMed/NCBI
30	Mishra S, Yadav T and Rani V: Exploring miRNA based approaches in cancer diagnostics and therapeutics. Crit Rev Oncol Hematol. 98:12–23. 2016. View Article : Google Scholar : PubMed/NCBI
31	Nohata N, Hanazawa T, Kikkawa N, Mutallip M, Fujimura L, Yoshino H, Kawakami K, Chiyomaru T, Enokida H, Nakagawa M, et al: Caveolin-1 mediates tumor cell migration and invasion and its regulation by miR-133a in head and neck squamous cell carcinoma. Int J Oncol. 38:209–217. 2011.PubMed/NCBI
32	Xu M and Wang YZ: miR133a suppresses cell proliferation, migration and invasion in human lung cancer by targeting MMP14. Oncol Rep. 30:1398–1404. 2013. View Article : Google Scholar : PubMed/NCBI
33	Chen G, Fang T, Huang Z, Qi Y, Du S, Di T, Lei Z, Zhang X and Yan W: MicroRNA-133a inhibits osteosarcoma cells proliferation and invasion via targeting IGF-1R. Cell Physiol Biochem. 38:598–608. 2016. View Article : Google Scholar : PubMed/NCBI
34	Sakr M, Takino T, Sabit H, Nakada M, Li Z and Sato H: miR-150-5p and miR-133a suppress glioma cell proliferation and migration through targeting membrane-type-1 matrix metalloproteinase. Gene. 587:155–162. 2016. View Article : Google Scholar : PubMed/NCBI
35	Ye ZQ, Wang T and Song W: Long noncoding RNAs in prostate cancer. Zhonghua Nan Ke Xue. 20:963–968. 2014.(In Chinese). PubMed/NCBI
36	Hirata H, Hinoda Y, Shahryari V, Deng G, Nakajima K, Tabatabai ZL, Ishii N and Dahiya R: Long noncoding RNA MALAT1 promotes aggressive renal cell carcinoma through Ezh2 and interacts with miR-205. Cancer Res. 75:1322–1331. 2015. View Article : Google Scholar : PubMed/NCBI
37	Chen DL, Ju HQ, Lu YX, Chen LZ, Zeng ZL, Zhang DS, Luo HY, Wang F, Qiu MZ, Wang DS, et al: Long non-coding RNA XIST regulates gastric cancer progression by acting as a molecular sponge of miR-101 to modulate EZH2 expression. J Exp Clin Cancer Res. 35:1422016. View Article : Google Scholar : PubMed/NCBI
38	Liang WC, Fu WM, Wong CW, Wang Y, Wang WM, Hu GX, Zhang L, Xiao LJ, Wan DC, Zhang JF and Waye MM: The lncRNA H19 promotes epithelial to mesenchymal transition by functioning as miRNA sponges in colorectal cancer. Oncotarget. 6:22513–22525. 2015. View Article : Google Scholar : PubMed/NCBI
39	Sarver AL and Subramanian S: Competing endogenous RNA database. Bioinformation. 8:731–733. 2012. View Article : Google Scholar : PubMed/NCBI